Indirizzo: Via Portuense, 292     Telefono: +39 06.55170.1    

Menu

INMI Lazzaro Spallanzani
Istituto Nazionale Malattie Infettive

Menu principale

Pubblicazioni 2016

Produzione Scientifica 2016

  1. Abbate I, Piralla A, Calvario A, Callegaro A, Giraldi C, Lunghi G, Gennari W, Sodano G, Ravanini P, Conaldi PG, Vatteroni M, Gaeta A, Paba P, Cavallo R, Baldanti F, Lazzarotto T; AMCLI − Infections in Transplant Working Group GLaIT. Nation-wide measure of variability in HCMV, EBV and BKV DNA quantification among centers involved in monitoring transplanted patients. J Clin Virol. 2016 Sep;82:76-83. Epub 2016 Jul 2. doi: 10.1016/j.jcv.2016.07.001
  2. Achhra AC, Mocroft A, Reiss P, Sabin C, Ryom L, de Wit S, Smith CJ, d’Arminio Monforte A, Phillips A, Weber R, Lundgren J, Law MG; D:A:D Study Group (… Antonucci G, Testa A, Narciso P, Vlassi C, Zaccarelli M …). Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:A:D study. HIV Med. 2016 Apr;17(4):255-68. Epub 2015 Jul 28. doi: 10.1111/hiv.12294
  3. Agrati C, Castilletti C, Casetti R, Sacchi A, Falasca L, Turchi F, Tumino N, Bordoni V, Cimini E, Viola D, Lalle E, Bordi L, Lanini S, Martini F, Nicastri E, Petrosillo N, Puro V, Piacentini M, Di Caro A, Kobinger GP, Zumla A, Ippolito G, Capobianchi MR. Longitudinal characterization of dysfunctional T cell-activation during human acute Ebola infection. Cell Death Dis. 2016 Mar 31;7:e2164. doi: 10.1038/cddis.2016.55
  4. Agrati C, Castilletti C, Cimini E, Romanelli A, Lapa D, Quartu S, Martini F, Capobianchi MR. Antiviral activity of human Vδ2 T-cells against WNV includes both cytolytic and non-cytolytic mechanisms. New Microbiol. 2016 Feb;39(2):139-42.
  5. Alteri C, Surdo M, Di Maio VC, Di Santo F, Costa G, Parrotta L, Romeo I, Gori C, Santoro MM, Fedele V, Carta S, Continenza F, Pinnetti C, Bellagamba R, Liuzzi G, Orchi N, Latini A, Bertoli A, Girardi E, Alcaro S, Giuliani M, Petrosillo N, Andreoni M, Antinori A, Monforte AD, Ceccherini-Silberstein F, Artese A, Perno CFd, Svicher V. The HIV-1 reverse transcriptase polymorphism A98S improves the response to tenofovir disoproxil fumarate+emtricitabine-containing HAART both in vivo and in vitro. J Glob Antimicrob Resist. 2016 Jul 25;7:1-7. [Epub ahead of print] doi: 10.1016/j.jgar.2016.06.005
  6. Amendola A, Pisciotta M, Aleo L, Ferraioli V, Angeletti C, Capobianchi MR. Evaluation of the Aptima(®) HIV-1 Quant Dx assay for HIV-1 RNA viral load detection and quantitation in plasma of HIV-1-infected individuals: A comparison with Abbott RealTime HIV-1 assay. J Med Virol. 2016 Sep;88(9):1535-44. doi: 10.1002/jmv.24493
  7. Andreoni M, Teti E, Antinori A, Milazzoi L, Sollima S, Rizzardini G, Di Biagio A, Saracino A, Bruno R, Borghi V, De Luca A, Cattelan A, Hasson H, Taliani G, Monforte AD, Mastroianni CM, Di Perri G, Bigoni S, Puoti M, Spinetti A, Gori A, Boffa N, Bruno C, Giacometti A, Parruti G, Vullo V, Chirianni A, Pennica A, Pasquazzi C, Segala D, Sarmati L; SIMIT (Società Italiana di Malattie Infettive e Tropicali).. Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Combination Treatment in Patients with HIV/HCV Co-Infection: Results of an Italian Compassionate Use Program. Clin Infect Dis. 2016 Dec 22. pii: ciw846. [Epub ahead of print] doi: 10.1093/cid/ciw846
  8. Ansumana R, Keitell S, Roberts GM, Ntoumi F, Petersen E, Ippolito G, Zumla A. Impact of Infectious Disease Epidemics on Tuberculosis Diagnostic, Management and Prevention Services: Experiences and Lessons from the 2014-2015 Ebola Virus Disease Outbreak in West Africa. Int J Infect Dis. 2016 Nov 3. pii: S1201-9712(16)31194-8. 0 [Epub ahead of print] doi: 10.1016/j.ijid.2016.10.01
  9. Antinori A, Marcotullio S, Andreoni M, Chirianni A, d’Arminio Monforte A, Di Biagio A, Galli M, Mazzotta F, Mussini C, Puoti M, Lazzarin A; Italian HIV Guidelines Working Group. Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2015. New Microbiol. 2016 Apr;39(2):93-109.
  10. Antinori A, Meraviglia P, Monforte Ad, Castagna A, Mussini C, Bini T, Gianotti N, Rusconi S, Colella E, Airoldi G, Mancusi D, Termini R. Effectiveness, durability, and safety of darunavir/ritonavir in HIV-1-infected patients in routine clinical practice in Italy: a postauthorization noninterventional study. Drug Des Devel Ther. 2016 May 6;10:1589-603. eCollection 2016. doi: 10.2147/DDDT.S104875
  11. Antonioli M, Di Rienzo M, Piacentini M, Fimia GM. Emerging Mechanisms in Initiating and Terminating Autophagy. Trends Biochem Sci. 2016 Oct 17. pii: S0968-0004(16)30171-2. doi: 10.1016/j.tibs.2016.09.008
  12. Armenia D, Di Carlo D, Calcagno A, Vendemiati G, Forbici F, Bertoli A, Berno G, Carta S, Continenza F, Fedele V, Bellagamba R, Cicalini S, Ammassari A, Libertone R, Zaccarelli M, Ghisetti V, Andreoni M, Ceccherini-Silberstein F, Bonora S, Di Perri G, Antinori A, Perno CF, Santoro MM. Pre-existent NRTI and NNRTI resistance impacts on maintenance of virological suppression in HIV-1-infected patients who switch to a tenofovir/emtricitabine/rilpivirine single-tablet regimen. J Antimicrob Chemother. 2016 Dec 20. pii: dkw512. doi: 10.1093/jac/dkw512 [Epub ahead of print]
  13. Armenia D, Di Carlo D, Maffongelli G, Borghi V, Alteri C, Forbici F, Bertoli A, Gori C, Giuliani M, Nicastri E, Zaccarelli M, Pinnetti C, Cicalini S, D’Offizi G, Ceccherini-Silberstein F, Mussini C, Antinori A, Andreoni M, Perno CF, Santoro MM. Virological response and resistance profile in HIV-1-infected patients starting darunavir-containing regimens. HIV Med. 2016 Jun 28. [Epub ahead of print] doi: 10.1111/hiv.12388
  14. Assenza F, Tombini M, Assenza G, Campana C, Benvenga A, Brunelli N, Ulivi M, Rizzo AC, Corpolongo A, Giancola ML, Nicastri E, Di Lazzaro V. Dengue encephalitis presenting with nonconvulsive status epilepticus: A case report. Clin Neurol Neurosurg. 2016 Aug 28;150:89-91. [Epub ahead of print] doi: 10.1016/j.clineuro.2016.08.027
  15. Azhar EI, Lanini S, Ippolito G, Zumla A. The Middle East Respiratory Syndrome Coronavirus – A Continuing Risk to Global Health Security. Adv Exp Med Biol. 2016 Dec 14. [Epub ahead of print] doi: 10.1007/5584_2016_133
  16. Baiocchini A, Montaldo C, Conigliaro A, Grimaldi A, Correani V, Mura F, Ciccosanti F, Rotiroti N, Brenna A, Montalbano M, D’Offizi G, Capobianchi MR, Alessandro R, Piacentini M, Schininà ME, Maras B, Del Nonno F, Tripodi M, Mancone C. Extracellular Matrix Molecular Remodeling in Human Liver Fibrosis Evolution. PLoS One. 2016 Mar 21;11(3):e0151736. eCollection 2016. doi: 10.1371/journal.pone.0151736
  17. Barcellini L, Borroni E, Brown J, Brunetti E, Campisi D, Castellotti PF, Codecasa LR, Cugnata F, Di Serio C, Ferrarese M, Goletti D, Lipman M, Rancoita PM, Russo G, Tadolini M, Vanino E, Cirillo DM. First evaluation of QuantiFERON-TB Gold Plus performance in contact screening. Eur Respir J. 2016 Jul 7. pii: ERJ-00510-2016. [Epub ahead of print] doi: 10.1183/13993003.00510-2016
  18. Barcellini L, Borroni E, Brown J, Brunetti E, Codecasa L, Cugnata F, Dal Monte P, Di Serio C, Goletti D, Lombardi G, Lipman M, Rancoita PM, Tadolini M, Cirillo DM. First independent evaluation of QuantiFERON-TB Plus performance. Eur Respir J. 2016 Feb 11. pii: ERJ-02033-2015. [Epub ahead of print] doi: 10.1183/13993003.02033-2015
  19. Battistelli C, Cicchini C, Santangelo L, Tramontano A, Grassi L, Gonzalez FJ, de Nonno V, Grassi G, Amicone L, Tripodi M. The Snail repressor recruits EZH2 to specific genomic sites through the enrollment of the lncRNA HOTAIR in epithelial-to-mesenchymal transition. Oncogene. 2016 Jul 25. [Epub ahead of print] doi: 10.1038/onc.2016.260
  20. Boer MC, van Meijgaarden KE, Goletti D, Vanini V, Prins C, Ottenhoff TH, Joosten SA. KLRG1 and PD-1 expression are increased on T-cells following tuberculosis-treatment and identify cells with different proliferative capacities in BCG-vaccinated adults. Tuberculosis (Edinb). 2016 Mar;97:163-71. Epub 2015 Dec 8. doi: 10.1016/j.tube.2015.11.008
  21. Boettiger DC, Sabin CA, Grulich A, Ryom L, Bonnet F, Reiss P, Monforte Ad, Kirk O, Phillips A, Bower M, Fätkenheuer G, Lundgren JD, Law M; Data collection on Adverse events of Anti-HIV Drugs (D:A:D) study group. (… Antonucci G, Testa A, Narciso P, Vlassi M, Zaccarelli M, Antinori A, Gallo L, Nicastri E, Acinapura R, Libertone R …). Is nelfinavir exposure associated with cancer incidence in HIV-positive individuals? AIDS. 2016 Jun 19;30(10):1629-37. doi: 10.1097/QAD.0000000000001053
  22. Bonovas S, Minozzi S, Lytras T, González-Lorenzo M, Pecoraro V, Colombo S, Polloni I, Moja L, Cinquini M, Marino V, Goletti D, Matucci A, Tocci G, Milano GM, Scarpa R, Cantini F. Risk of malignancies using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysis. Expert Opin Drug Saf. 2016 Dec;15(sup1):35-54. doi: 10.1080/14740338.2016.1238458
  23. Bordi L, Avsic-Zupanc T, Lalle E, Vairo F, Capobianchi MR, da Costa Vasconcelos PF. Emerging Zika Virus Infection: A Rapidly Evolving Situation. Adv Exp Med Biol. 2016 Dec 29. [Epub ahead of print] doi: 10.1007/5584_2016_187
  24. Bordoni V, Sacchi A, Cimini E, Casetti R, Tumino N, Ammassari A, Agrati C, Martini F. The Different Roles of Interleukin 7 and Interleukin 18 in Affecting Lymphoid Hematopoietic Progenitor Cells and CD4 Homeostasis in Naive Primary and Chronic HIV-Infected Patients. Clin Infect Dis. 2016 Dec 15;63(12):1683-1684. doi: 10.1093/cid/ciw640
  25. Bouteloup V, Sabin C, Mocroft A, Gras L, Pantazis N, Le Moing V, d’Arminio Monforte A, Mary-Krause M, Roca B, Miro JM, Battegay M, Brockmeyer N, Berenguer J, Morlat P, Obel N, De Wit S, Fätkenheuer G, Zangerle R, Ghosn J, Pérez-Hoyos S, Campbell M, Prins M, Chêne G, Meyer L, Dorrucci M, Torti C, Thiébaut R; Standard Reference Distribution of CD4 Response to HAART Project Team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord (… Antinori A …). Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naïve patients. HIV Med. 2016 Sep 14. [Epub ahead of print] doi: 10.1111/hiv.12389
  26. Bracaglia G, Ranno S, Mancinelli L, Santoro M, Cerroni L, Massone C, Sangueza O, Bravo FG, Diociaiuti A, Nicastri E, Muraca M, El Hachem M, Boldrini R, Callea F, Putignani L. A waterborn zoonotic helminthiase in an Italian diver: a case report of a cutaneous Sparganum infection and a review of European cases. Pathog Glob Health. 2016 Jan 9:1-4. [Epub ahead of print] doi: 10.1080/20477724.2015.1123901
  27. Bruni R, Taffon S, Equestre M, Chionne P, Madonna E, Rizzo C, Tosti ME, Alfonsi V, Ricotta L, De Medici D, Di Pasquale S, Scavia G, Pavoni E, Losio MN, Romanò L, Zanetti AR, Morea A, Pacenti M, Palù G, Capobianchi MR, Chironna M, Pompa MG, Ciccaglione AR; Italian National Task Force on Hepatitis A. Key Role of Sequencing to Trace Hepatitis A Viruses Circulating in Italy During a Large Multi-Country European Foodborne Outbreak in 2013. PLoS One. 2016 Feb 22;11(2):e0149642. eCollection 2016. doi: 10.1371/journal.pone.0149642.
  28. Caglioti C, Selleri M, Rozera G, Giombini E, Zaccaro P, Valli MB, Capobianchi MR. In-Depth Analysis of HA and NS1 Genes in A(H1N1)pdm09 Infected Patients. PLoS One. 2016 May 17;11(5):e0155661. eCollection 2016. doi: 10.1371/journal.pone.0155661
  29. Cancer Project Working Group for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study in EuroCoord. (… Antinori A …). Changing Incidence and Risk Factors for Kaposi Sarcoma by Time Since Starting Antiretroviral Therapy: Collaborative Analysis of 21 European Cohort Studies. Clin Infect Dis. 2016 Nov 15;63(10):1373-1379. doi: 10.1093/cid/ciw562
  30. Capone A, Cafiso V, Campanile F, Parisi G, Mariani B, Petrosillo N, Stefani S. In vivo development of daptomycin resistance in vancomycin-susceptible methicillin-resistant Staphylococcus aureus severe infections previously treated with glycopeptides. Eur J Clin Microbiol Infect Dis. 2016 Apr;35(4):625-31. doi: 10.1007/s10096-016-2581-4
  31. Caraffa E, Schepisi MS, Gualano G, Parracino MP, Rianda A, Corpolongo A, Pinnetti C, Galati V, Carballo M, Ippolito G, Palmieri F, Girardi E. The diabetes-tuberculosis co-epidemic: the role of international migration. Int J Tuberc Lung Dis. 2016 Jun;20(6):771-7. doi: 10.5588/ijtld.15.0295
  32. Castagna A, Monno L, Carta S, Galli L, Carrara S, Fedele V, Punzi G, Fanti I, Caramello P, Lepri AC, De Luca A, Ceccherini-Silberstein F, Monforte AD; ICONA Foundation Study Group.. Switch of predicted HIV-1 tropism in treated subjects and its association with disease progression. Medicine (Baltimore). 2016 Nov;95(44):e5222. doi: 10.1097/MD.0000000000005222
  33. Chinello P, Petrosillo N. Pharmacological treatment of HIV-associated pulmonary hypertension. Expert Rev Clin Pharmacol. 2016 Mar 2:1-11. [Epub ahead of print] doi: 10.1586/17512433.2016.1151785
  34. Cicchillitti L, Manni I, Mancone C, Regazzo G, Spagnuolo M, Alonzi T, Carlomosti F, Dell’Anna ML, Dell’Omo G, Picardo M, Ciana P, Capogrossi MC, Tripodi M, Magenta A, Rizzo MG, Gurtner A, Piaggio G. The laminA/NF-Y protein complex reveals an unknown transcriptional mechanism on cell proliferation. Oncotarget. 2016 Oct 26. [Epub ahead of print] doi: 10.18632/oncotarget.12914
  35. Cioni G, Viale P, Frasson S, Cipollini F, Menichetti F, Petrosillo N, Brunati S, Spigaglia P, Vismara C, Bielli A, Barbanti F, Landini G, Panigada G, Gussoni G, Bonizzoni E, Gesu GP; Research Department of FADOI.. Epidemiology and outcome of Clostridium difficile infections in patients hospitalized in Internal Medicine: findings from the nationwide FADOI-PRACTICE study. BMC Infect Dis. 2016 Nov 8;16(1):656. doi: 10.1186/s12879-016-1961-9
  36. Cirillo DM, Barcellini L, Goletti D. Preliminary data on precision of QuantiFERON-TB Plus performance. Eur Respir J. 2016 Sep;48(3):955-6. doi: 10.1183/13993003.01084-2016
  37. Colavita F, Quartu S, Lalle E, Bordi L, Lapa D, Meschi S, Vulcano A, Toffoletti A, Bordi E, Paglia MG, Di Caro A, Ippolito G, Capobianchi MR, Castilletti C. Evaluation of the inactivation effect of Triton X-100 on Ebola virus infectivity. J Clin Virol. 2016 Nov 22;86:27-30. [Epub ahead of print] doi: 10.1016/j.jcv.2016.11.009
  38. Costarelli S, Cozzi-Lepri A, Lapadula G, Bonora S, Madeddu G, Maggiolo F, Antinori A, Galli M, Di Perri G, Viale P, d’Arminio Monforte A, Gori A; ICONA Foundation Study Group.. Long-Term Durability of Tenofovir-Based Antiretroviral Therapy in Relation to the Co-Administration of Other Drug Classes in Routine Clinical Practice. PLoS One. 2016 Oct 7;11(10):e0160761. doi: 10.1371/journal.pone.0160761
  39. Cozzolino AM, Noce V, Battistelli C, Marchetti A, Grassi G, Cicchini C, Tripodi M, Amicone L. Modulating the Substrate Stiffness to Manipulate Differentiation of Resident Liver Stem Cells and to Improve the Differentiation State of Hepatocytes. Stem Cells Int. 2016;2016:5481493. Epub 2016 Jan 12. doi: 10.1155/2016/5481493
  40. Crepet A, Repetto E, Al Rousan A, Sané Schepisi M, Girardi E, Prestileo T, Codecasa L, Garelli S, Corrao S, Ippolito G, Decroo T, Maccagno B. Lessons learnt from TB screening in closed immigration centres in Italy. Int Health. 2016 Sep;8(5):324-9. doi: 10.1093/inthealth/ihw025
  41. Dara M, Solovic I, Goletti D, Sotgiu G, Centis R, D’Ambrosio L, Ward B, Teixeira V, Gratziou C, Migliori GB. Preventing and controlling tuberculosis among refugees in Europe: more is needed. Eur Respir J. 2016 Jul;48(1):272-4. doi: 10.1183/13993003.00329-2016
  42. Dara M, Solovic I, Sotgiu G, D’Ambrosio L, Centis R, Goletti D, Duarte R, Aliberti S, de Benedictis FM, Bothamley G, Schaberg T, Abubakar I, Ward B, Teixeira V, Gratziou C, Migliori GB. Statement of the European Respiratory Society and the European Region of the International Union Against Tuberculosis and Lung Disease: call for urgent actions to ensure access to early diagnosis and care of tuberculosis among refugees. Eur Respir J. 2016 Mar 23. pii: ERJ-00377-2016. [Epub ahead of print] doi: 10.1183/13993003.00377-2016
  43. Dara M, Solovic I, Sotgiu G, D’Ambrosio L, Centis R, Tran R, Goletti D, Duarte R, Aliberti S, de Benedictis FM, Bothamley G, Schaberg T, Abubakar I, Teixeira V, Ward B, Gratziou C, Migliori GB. Tuberculosis care among refugees arriving in Europe: a ERS/WHO Europe Region survey of current practices. Eur Respir J. 2016 Sep;48(3):808-17. doi: 10.1183/13993003.00840-2016
  44. D’Arezzo S, Mazzarelli A, Venditti C, Nisii C, Petrosillo N, De Giuli C, Vulcano A, Paglia MG, Bordi E, Di Caro A, Taglietti F. Ceftaroline Plus Ampicillin Against Gram-Positive Organisms: Results from E-Test Synergy Assays. Microb Drug Resist. 2016 Aug 15. [Epub ahead of print] doi: 10.1089/mdr.2016.0030
  45. d’Arminio Monforte A, Cozzi-Lepri A, Maggiolo F, Rizzardini G, Manconi PE, Gianotti N, Quirino T, Pinnetti C, Rusconi S, De Luca A, Antinori A; Icona Foundation Study cohort. Response to First-Line Ritonavir-Boosted Protease Inhibitors (PI/r)-Based Regimens in HIV Positive Patients Presenting to Care with Low CD4 Counts: Data from the Icona Foundation Cohort. PLoS One. 2016 Jun 27;11(6):e0156360. eCollection 2016. doi: 10.1371/journal.pone.0156360
  46. Davies K, Davis G, Barbut F, Eckert C, Petrosillo N, Wilcox MH. Variability in testing policies and impact on reported Clostridium difficile infection rates: results from the pilot Longitudinal European Clostridium difficile Infection Diagnosis surveillance study (LuCID). Eur J Clin Microbiol Infect Dis. 2016 Dec;35(12):1949-1956. doi: 10.1007/s10096-016-2746-1
  47. De Luca A, Flandre P, Dunn D, Zazzi M, Wensing A, Santoro MM, Günthard HF, Wittkop L, Kordossis T, Garcia F, Castagna A, Cozzi-Lepri A, Churchill D, De Wit S, Brockmeyer NH, Imaz A, Mussini C, Obel N, Perno CF, Roca B, Reiss P, Schülter E, Torti C, van Sighem A, Zangerle R, Descamps D; CHAIN and COHERE in EuroCoord.. Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIV-1 subtype B and non-subtype B receiving a salvage regimen. J Antimicrob Chemother. 2016 May;71(5):1352-60. doi: 10.1093/jac/dkv465
  48. De Nardo P, Gentilotti E, Nguhuni B, Vairo F, Chaula Z, Nicastri E, Nassoro MM, Bevilacqua N, Ismail A, Savoldi A, Zumla A, Ippolito G. Post-caesarean section surgical site infections at a Tanzanian tertiary hospital: a prospective observational study. J Hosp Infect. 2016 Aug;93(4):355-9. doi: 10.1016/j.jhin.2016.02.021
  49. De Nardo P, Gentilotti E, Nguhuni B, Vairo F, Chaula Z, Nicastri E, Ippolito G. Efavirenz-based antiretroviral therapy versus nevirapine-including regimens for prevention of mother-to-child transmission of HIV option B plus in resource-limited settings: is there anything missing? Expert Rev Anti Infect Ther. 2016;14(1):19-27. doi: 10.1586/14787210.2016.1116383
  50. De Santis Puzzonia M, Cozzolino AM, Grassi G, Bisceglia F, Strippoli R, Guarguaglini G, Citarella F, Sacchetti B, Tripodi M, Marchetti A, Amicone L. TGFbeta Induces Binucleation/Polyploidization in Hepatocytes through a Src-Dependent Cytokinesis Failure. PLoS One. 2016 Nov 28;11(11):e0167158. doi: 10.1371/journal.pone.0167158
  51. D’Eletto M, Farrace MG, Piacentini M, Rossin F. Assessing the Catalytic Activity of Transglutaminases in the Context of Autophagic Responses. Methods Enzymol. 2017;587:511-520. Epub 2016 Nov 29. doi: 10.1016/bs.mie.2016.10.011
  52. Delogu G, Vanini V, Cuzzi G, Chiacchio T, De Maio F, Battah B, Pinnetti C, Sampaolesi A, Antinori A, Goletti D. Lack of Response to HBHA in HIV-Infected Patients with Latent Tuberculosis Infection. Scand J Immunol. 2016 Dec;84(6):344-352. doi: 10.1111/sji.12493
  53. Deodato D, Maccari G, De Luca F, Sanfilippo S, Casian A, Martini R, D’Arezzo S, Bonchi C, Bugli F, Posteraro B, Vandeputte P, Sanglard D, Docquier JD, Sanguinetti M, Visca P, Botta M. Biological Characterization and in Vivo Assessment of the Activity of a New Synthetic Macrocyclic Antifungal Compound. J Med Chem. 2016 Apr 28;59(8):3854-66. Epub 2016 Apr 19 doi: 10.1021/acs.jmedchem.6b00018
  54. d’Ettorre G, Ceccarelli G, Zaccarelli M, Ascoli-Bartoli T, Bianchi L, Bellelli V, De Girolamo G, Serafino S, Giustini N, Mastroianni CM, Vullo V. Impact of switching from lopinavir/ritonavir to boosted and un-boosted atazanavir on glucose metabolism: the ATAzanavir & GLUcose metabolism (ATAGLU) study. Int J STD AIDS. 2016 Jul;27(8):638-43. doi: 10.1177/0956462415590724
  55. Di Bella S, Ascenzi P, Siarakas S, Petrosillo N, di Masi A. Clostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal Effects. Toxins (Basel). 2016 May 3;8(5). pii: E134. doi: 10.3390/toxins8050134
  56. Di Biagio A, Cozzi-Lepri A, Prinapori R, Angarano G, Gori A, Quirino T, De Luca A, Costantini A, Mussini C, Rizzardini G, Castagna A, Antinori A, d’Arminio Monforte A; ICONA Foundation Study Group. Discontinuation of Initial Antiretroviral Therapy in Clinical Practice: Moving Toward Individualized Therapy. J Acquir Immune Defic Syndr. 2016 Mar 1;71(3):263-71. doi: 10.1097/QAI.0000000000000849
  57. Diaz-Hidalgo L, Altuntas S, Rossin F, D’Eletto M, Marsella C, Farrace MG, Falasca L, Antonioli M, Fimia GM, Piacentini M. Transglutaminase type 2-dependent selective recruitment of proteins into exosomes under stressful cellular conditions. Biochim Biophys Acta. 2016 Aug;1863(8):2084-92. doi: 10.1016/j.bbamcr.2016.05.005
  58. Donato MF, Morelli C, Romagnoli R, Invernizzi F, Mazzarelli C, Iemmolo RM, Montalbano M, Lenci I, Bhoori S, Pieri G, Berardi S, Caraceni P, Martini S; ITACOPS-SOF Bridging Study Group.. Prevention of hepatitis C recurrence by bridging sofosbuvir/ribavirin from pre- to post-liver transplant: a real-life strategy. Liver Int. 2016 Nov 19. [Epub ahead of print] doi: 10.1111/liv.13322
  59. Durante-Mangoni E, Andini R, Signoriello S, Cavezza G, Murino P, Buono S, De Cristofaro M, Taglialatela C, Bassetti M, Malacarne P, Petrosillo N, Corcione A, Viscoli C, Utili R, Gallo C. Acute kidney injury during colistin therapy: a prospective study in patients with extensively-drug resistant Acinetobacter baumannii infections. Clin Microbiol Infect. 2016 Dec;22(12):984-989. doi: 10.1016/j.cmi.2016.08.004
  60. Durante-Mangoni E, Pafundi PC, Ravasio V, Barbaro F, Bassetti M, Chinello P, Falcone M, Pasticci MB, Scotton PG, Stellini R, Tripodi MF, Utili R, Rizzi M. Current features of infective endocarditis in persons on hemodialysis: a prevalence study with case control design from the prospective multicenter SEI cohort. Infection. 2016 Aug;44(4):467-74. doi: 10.1007/s15010-015-0870-y
  61. Dustin LB, Bartolini B, Capobianchi MR, Pistello M. Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response to therapy. Clin Microbiol Infect. 2016 Oct;22(10):826-832. doi: 10.1016/j.cmi.2016.08.025
  62. Ferraro F, Piselli P, Pittalis S, Ruscitti LE, Cimaglia C, Ippolito G, Puro V. Surgical site infection after caesarean section: space for post-discharge surveillance improvements and reliable comparisons. New Microbiol. 2016 Feb;39(2):134-8.
  63. Floridia M, Masuelli G, Meloni A, Cetin I, Tamburrini E, Cavaliere AF, Dalzero S, Sansone M, Alberico S, Guerra B, Spinillo A, Chiadò Fiorio Tin M, Ravizza M; Italian Group on Surveillance on Antiretroviral Treatment in Pregnancy (… Capone A, Pinnetti C, Liuzzi G, Tozzi V …). Amniocentesis and chorionic villus sampling in HIV-infected pregnant women: a multicentre case series. BJOG. 2016 Jun 20. [Epub ahead of print] doi: 10.1111/1471-0528.14183
  64. Floridia M, Pirillo MF, Degli Antoni A, Molinari A, Tamburrini E, Pinnetti C, Guaraldi G, Nardini G, Masuelli G, Dalzero S, Cetin I, Sansone M, Amici R, Ravizza M; Italian Group on Surveillance on Antiretroviral Treatment in Pregnancy.. Pregnancy outcomes and cytomegalovirus DNAaemia in HIV-infected pregnant women with CMV. Clin Microbiol Infect. 2016 Sep;22(9):818-820. doi: 10.1016/j.cmi.2016.06.017
  65. Floridia M, Tamburrini E, Masuelli G, Martinelli P, Spinillo A, Liuzzi G, Vimercati A, Alberico S, Maccabruni A, Pinnetti C, Frisina V, Dalzero S, Ravizza M; Italian Group for Surveillance of Antiretroviral Treatment in Pregnancy. Rate, correlates and outcomes of repeat pregnancy in HIV-infected women. HIV Med. 2016 Dec 21. [Epub ahead of print] doi: 10.1111/hiv.12473
  66. Fokam J, Takou D, Santoro MM, Akonie HZ, Kouanfack C, Ceccherini-Silberstein F, Colizzi V, Perno CFt, Ndjolo A. Short Communication: Population-Based Surveillance of HIV-1 Drug Resistance in Cameroonian Adults Initiating Antiretroviral Therapy According to the World Health Organization Guidelines. AIDS Res Hum Retroviruses. 2016 Apr;32(4):329-33. Epub 2016 Jan 20. doi: 10.1089/aid.2015.0065
  67. Fontana RJ, Brown RS Jr, Moreno-Zamora A, Prieto M, Joshi S, Londoño MC, Herzer K, Chacko KR, Stauber RE, Knop V, Jafri SM, Castells L, Ferenci P, Torti C, Durand CM, Loiacono L, Lionetti R, Bahirwani R, Weiland O, Mubarak A, ElSharkawy AM, Stadler B, Montalbano M, Berg C, Pellicelli AM, Stenmark S, Vekeman F, Ionescu-Ittu R, Emond B, Reddy KR. Daclatasvir combined with sofosbuvir or simeprevir in liver transplant recipients with severe recurrent hepatitis C infection. Liver Transpl. 2016 Apr;22(4):446-58. doi: 10.1002/lt.24416
  68. Foster GR, Coppola C, Derbala M, Ferenci P, Orlandini A, Reddy KR, Tallarico L, Shiffman ML, Ahlers S, Bakalos G, Hassanein T; GUARD-C Study Group (… Montalbano M …). Impact of Safety-Related Dose Reductions or Discontinuations on Sustained Virologic Response in HCV-Infected Patients: Results from the GUARD-C Cohort. PLoS One. 2016 Mar 28;11(3):e0151703. doi: 10.1371/journal.pone.0151703
  69. Frustaci A, Petrosillo N, Ippolito G, Chimenti Cd. Transitory ventricular tachycardia associated with influenza A infection of cardiac conduction tissue. Infection. 2016 Jun;44(3):353-6. doi: 10.1007/s15010-016-0892-0
  70. Fryer JF, Heath AB, Minor PD; Collaborative Study Group (… Capobianchi MR, Abbate I …) A collaborative study to establish the 1st WHO International Standard for human cytomegalovirus for nucleic acid amplification technology. Biologicals. 2016 Jul;44(4):242-51. doi: 10.1016/j.biologicals.2016.04.005
  71. Fusco M, Piselli P, Virdone S, Di Cicco P, Scognamiglio P, De Paoli P, Ciullo V, Verdirosi D, D’Orazio M, Dal Maso L, Girardi E, Franceschi S, Serraino D. Infection with hepatitis viruses, FIB-4 index and risk of hepatocellular carcinoma in southern Italy: a population-based cohort study. Infect Agent Cancer. 2016 Nov 3;11:54. doi: 10.1186/s13027-016-0101-x
  72. Galli L, Spagnuolo V, Bigoloni A, D’Arminio Monforte A, Montella F, Antinori A, Di Biagio A, Rusconi S, Guaraldi G, Di Giambenedetto S, Borderi M, Gibellini D, Caramatti G, Lazzarin A, Castagna A; MODAt Study Group.. Atazanavir/ritonavir monotherapy: 96 week efficacy, safety and bone mineral density from the MODAt randomized trial. J Antimicrob Chemother. 2016 Jun;71(6):1637-42. doi: 10.1093/jac/dkw031
  73. Garbuglia AR, Visco-Comandini U, Lionetti R, Lapa D, Castiglione F, D’Offizi G, Taibi C, Montalbano M, Capobianchi MR, Paci P. Ultrasensitive HCV RNA Quantification in Antiviral Triple Therapy: New Insight on Viral Clearance Dynamics and Treatment Outcome Predictors. PLoS One. 2016 Aug 25;11(8):e0158989. eCollection 2016. doi: 10.1371/journal.pone.0158989
  74. Gignoux E, Azman AS, de Smet M, Azuma P, Massaquoi M, Job D, Tiffany A, Petrucci R, Sterk E, Potet J, Suzuki M, Kurth A, Cannas A, Bocquin A, Strecker T, Logue C, Pottage T, Yue C, Cabrol JC, Serafini M, Ciglenecki I. Effect of Artesunate-Amodiaquine on Mortality Related to Ebola Virus Disease. N Engl J Med. 2016 Jan 7;374(1):23-32. doi: 10.1056/NEJMoa1504605
  75. Girard PM, Antinori A, Arribas JR, Ripamonti D, Bicer C, Netzle-Sveine B, Hadacek B, Moecklinghoff C. Week 96 efficacy and safety of darunavir/ritonavir monotherapy vs. darunavir/ritonavir with two nucleoside reverse transcriptase inhibitors in the PROTEA trial. HIV Med. 2016 Jun 9. [Epub ahead of print] doi: 10.1111/hiv.12386
  76. Gjærde LI, Shepherd L, Jablonowska E, Lazzarin A, Rougemont M, Darling K, Battegay M, Braun D, Martel-Laferriere V, Lundgren JD, Rockstroh JK, Gill J, Rauch A, Mocroft A, Klein MB, Peters L. Trends in Incidences and Risk Factors for Hepatocellular Carcinoma and Other Liver Events in HIV and Hepatitis C Virus-coinfected Individuals From 2001 to 2014: A Multicohort Study (… Zaccarelli M, Antinori A, Acinapura R, Plazzi M …). Clin Infect Dis. 2016 Sep 15;63(6):821-9. doi: 10.1093/cid/ciw380
  77. Grassi G, Di Caprio G, Fimia GM, Ippolito G, Tripodi M, Alonzi T. Hepatitis C virus relies on lipoproteins for its life cycle. World J Gastroenterol. 2016 Feb 14;22(6):1953-65. doi: 10.3748/wjg.v22.i6.1953
  78. Günther G, Lange C, Alexandru S, Altet N, Avsar K, Bang D, Barbuta R, Bothamley G, Ciobanu A, Crudu V, Danilovits M, Dedicoat M, Duarte R, Gualano G, Kunst H, de Lange W, Leimane V, Magis-Escurra C, McLaughlin AM, Muylle I, Polcová V, Popa C, Rumetshofer R, Skrahina A, Solodovnikova V, Spinu V, Tiberi S, Viiklepp P, van Leth F; for TBNET. Treatment Outcomes in Multidrug-Resistant Tuberculosis. N Engl J Med. 2016 Sep 15;375(11):1103-5. doi: 10.1056/NEJMc1603274
  79. Haggiag S, Prosperini L, Galgani S, Pozzilli C, Pinnetti C. Extratemporal herpes encephalitis during natalizumab treatment: A case report. Mult Scler Relat Disord. 2016 Nov;10:134-136. doi: 10.1016/j.msard.2016.10.002
  80. Hatleberg CI, Ryom L, El-Sadr W, Smith C, Weber R, Reiss P, Fontas E, Dabis F, Law M, Monforte Ad, De Wit S, Mocroft A, Phillips A, Lundgren JD, Sabin C; D:A:D Study Group. (… Antinori A, Gallo L, Nicastri E, Acinapura R, Libertone R, Zaccarelli M …). Improvements over time in short-term mortality following myocardial infarction in HIV-positive individuals. AIDS. 2016 Jun 19;30(10):1583-96. doi: 10.1097/QAD.0000000000001076
  81. Humphreys H, Becker K, Dohmen PM, Petrosillo N, Spencer M, van Rijen M, Wechsler-Fördös A, Pujol M, Dubouix A, Garau J. Staphylococcus aureus and surgical site infections: benefits of screening and decolonization before surgery. J Hosp Infect. 2016 Nov;94(3):295-304. doi: 10.1016/j.jhin.2016.06.011
  82. Ippolito G, Antonelli G. Emerging issues on hepatitis C virus infection after the introduction of the Directly Acting Antivirals. Clin Microbiol Infect. 2016 Oct;22(10):824-825. doi: 10.1016/j.cmi.2016.10.016
  83. Ippolito G, Lanini S, Brouqui P, Di Caro A, Vairo F, Fusco FM, Krishna S, Capobianchi MR, Kyobe-Bosa H, Puro V, Wölfel R, Avsic-Zupanc T, Ioannidis JP, Portella G, Kremsner P, Dar O, Bates M, Zumla A. Non-randomised Ebola trials-lessons for optimal outbreak research. Lancet Infect Dis. 2016 Apr;16(4):407-8. doi: 10.1016/S1473-3099(16)00132-8
  84. Joosten SA, van Meijgaarden KE, Del Nonno F, Baiocchini A, Petrone L, Vanini V, Smits HH, Palmieri F, Goletti D, Ottenhoff TH. Patients with Tuberculosis Have a Dysfunctional Circulating B-Cell Compartment, Which Normalizes following Successful Treatment. PLoS Pathog. 2016 Jun 15;12(6):e1005687. eCollection 2016 Jun. doi: 10.1371/journal.ppat.1005687
  85. Judd A, Lodwick R, Noguera-Julian A, Gibb DM, Butler K, Costagliola D, Sabin C, van Sighem A, Ledergerber B, Torti C, Mocroft A, Podzamczer D, Dorrucci M, De Wit S, Obel N, Dabis F, Cozzi-Lepri A, García F, Brockmeyer NH, Warszawski J, Gonzalez-Tome MI, Mussini C, Touloumi G, Zangerle R, Ghosn J, Castagna A, Fätkenheuer G, Stephan C, Meyer L, Campbell MA, Chene G, Phillips A; Pursuing Later Treatment Options II (PLATO II) Project Team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord (… Antinori A …). Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in Europe. HIV Med. 2016 Sep 14. [Epub ahead of print] doi: 10.1111/hiv.12411
  86. Kerber R, Krumkamp R, Diallo B, Jaeger A, Rudolf M, Lanini S, Bore JA, Koundouno FR, Becker-Ziaja B, Fleischmann E, Stoecker K, Meschi S, Mély S, Newman EN, Carletti F, Portmann J, Korva M, Wolff S, Molkenthin P, Kis Z, Kelterbaum A, Bocquin A, Strecker T, Fizet A, Castilletti C, Schudt G, Ottowell L, Kurth A, Atkinson B, Badusche M, Cannas A, Pallasch E, Bosworth A, Yue C, Pályi B, Ellerbrok H, Kohl C, Oestereich L, Logue CH, Lüdtke A, Richter M, Ngabo D, Borremans B, Becker D, Gryseels S, Abdellati S, Vermoesen T, Kuisma E, Kraus A, Liedigk B, Maes P, Thom R, Duraffour S, Diederich S, Hinzmann J, Afrough B, Repits J, Mertens M, Vitoriano I, Bah A, Sachse A, Boettcher JP, Wurr S, Bockholt S, Nitsche A, Županc TA, Strasser M, Ippolito G, Becker S, Raoul H, Carroll MW, De Clerck H, Van Herp M, Sprecher A, Koivogui L, Magassouba N, Keïta S, Drury P, Gurry C, Formenty P, May J, Gabriel M, Wölfel R, Günther S, Di Caro A. Analysis of Diagnostic Findings From the European Mobile Laboratory in Guéckédou, Guinea, March 2014 Through March 2015. J Infect Dis. 2016 Oct 15;214(suppl 3):S250-S257. doi: 10.1093/infdis/jiw269
  87. Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM, Adams PD, Adeli K, Adhihetty PJ, Adler SG, Agam G, Agarwal R, Aghi MK, Agnello M, Agostinis P, Aguilar PV, Aguirre-Ghiso J, Airoldi EM, Ait-Si-Ali S, Akematsu T, Akporiaye ET, Al-Rubeai M, Albaiceta GM, Albanese C, … Goletti D, Corazzari M, Fimia GM, Piacentini M … Zhu WG, Zhu W, Zhu XF, Zhu Y, Zhuang SM, Zhuang X, Ziparo E, Zois CE, Zoladek T, Zong WX, Zorzano A, Zughaier SM. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 2016 Jan 2;12(1):1-222. doi: 10.1080/15548627.2015.1100356
  88. Kowalik MA, Perra A, Ledda-Columbano GM, Ippolito G, Piacentini M, Columbano A, Falasca L. Induction of autophagy promotes the growth of early preneoplastic rat liver nodules. Oncotarget. 2016 Feb 2;7(5):5788-99. doi: 10.18632/oncotarget.6810
  89. Krähling V, Becker D, Rohde C, Eickmann M, Eroğlu Y, Herwig A, Kerber R, Kowalski K, Vergara-Alert J, Becker S; European Mobile Laboratory consortium (… Cannas A, Carletti F, Castilletti C, Colavita F, Meschi S, Quartu S, Capobianchi MR, Ippolito G, Di Caro A …). Development of an antibody capture ELISA using inactivated Ebola Zaire Makona virus. Med Microbiol Immunol. 2016 Apr;205(2):173-83. Epub 2015 Oct 16. doi: 10.1007/s00430-015-0438-6
  90. Lambert-Niclot S, George EC, Pozniak A, White E, Schwimmer C, Jessen H, Johnson M, Dunn D, Perno CF, Clotet B, Plettenberg A, Blaxhult A, Palmisano L, Wittkop L, Calvez V, Marcelin AG, Raffi F; NEAT 001/ANRS 143 Study Group (… Ammassari A, Antinori A …). Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART. J Antimicrob Chemother. 2016 Apr;71(4):1056-62. Epub 2015 Dec 24. doi: 10.1093/jac/dkv427
  91. Lange C, van Leth F, Sester M; TBnet (… Girardi E, Goletti D …). Viral Load and Risk of Tuberculosis in HIV Infection. J Acquir Immune Defic Syndr. 2016 Feb 1;71(2):e51-3. doi: 10.1097/QAI.0000000000000834
  92. Lanini S, Easterbrook PJ, Zumla A, Ippolito G. Hepatitis C: global epidemiology and strategies for control. Clin Microbiol Infect. 2016 Oct;22(10):833-838. doi: 10.1016/j.cmi.2016.07.035
  93. Latini A, Fabbiani M, Borghi V, Sterrantino G, Giannetti A, Lorenzini P, Loiacono L, Ammassari A, Bellagamba R, Colafigli M, D’Ettorre G, Di Giambenedetto S, Antinori A, Zaccarelli M. Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter observational study. BMC Infect Dis. 2016 Aug 11;16(1):401. doi: 10.1186/s12879-016-1703-z
  94. Latini A, Lora V, Zaccarelli M, Cristaudo A, Cota C. Unusual Presentation of Poppers Dermatitis. JAMA Dermatol. 2016 Dec 7. [Epub ahead of print] doi: 10.1001/jamadermatol.2016.4262
  95. Laut KG, Shepherd LC, Pedersen C, Rockstroh JK, Sambatakou H, Paduta D, Matulionyte R, Smiatacz T, Mulcahy F, Lundgren JD, Mocroft A, Kirk O; EuroSIDA in EuroCoord (… Zaccarelli M, Antinori A, Acinapura R, Plazzi M …). Associations between HIV-RNA-based indicators and virological and clinical outcomes. AIDS. 2016 Jul 31;30(12):1961-72. doi: 10.1097/QAD.0000000000001144
  96. Lazarus JV, Laut KG, Safreed-Harmon K, Peters L, Johnson M, Fätkenheuer G, Khromova I, Vandekerckhove L, Maciejewska K, Radoi R, Ridolfo AL, Mocroft A. Disparities in HIV clinic care across Europe: findings from the EuroSIDA clinic survey (… Zaccarelli M, Antinori A, Acinapura R, Plazzi M …). BMC Infect Dis. 2016 Jul 20;16:335. doi: 10.1186/s12879-016-1685-x
  97. Liuzzi G, Nicastri E, Puro V, Zumla A, Ippolito G. Zika virus in saliva-New challenges for prevention of human to human transmission. Eur J Intern Med. 2016 Sep;33:e20-1. doi: 10.1016/j.ejim.2016.04.022
  98. Liuzzi G, Puro V, Lanini S, Vairo F, Nicastri E, Capobianchi MR, Di Caro A, Piacentini M, Zumla A, Ippolito G. Zika virus and microcephaly: is the correlation causal or coincidental? New Microbiol. 2016 Feb;39(2):83-5.
  99. Llibre JM, Cozzi-Lepri A, Pedersen C, Ristola M, Losso M, Mocroft A, Mitsura V, Falconer K, Maltez F, Beniowski M, Vullo V, Hassoun G, Kuzovatova E, Szlavik J, Kuznetsova A, Stellbrink HJ, Duvivier C, Edwards S, Laut K, Paredes R; EuroSIDA Study (… Zaccarelli M, Antinori A, Acinapura R, Plazzi M …). Long-term effectiveness of unboosted atazanavir plus abacavir/lamivudine in subjects with virological suppression: A prospective cohort study. Medicine (Baltimore). 2016 Oct;95(40):e5020. doi: 10.1097/MD.0000000000005020
  100. Lo Dico A, Costa V, Martelli C, Diceglie C, Rajata F, Rizzo A, Mancone C, Tripodi M, Ottobrini L, Alessandro R, Conigliaro A. MiR675-5p Acts on HIF-1α to Sustain Hypoxic Responses: A New Therapeutic Strategy for Glioma. Theranostics. 2016 May 8;6(8):1105-18. eCollection 2016. doi: 10.7150/thno.14700
  101. Macciocchi D, Lanini S, Vairo F, Zumla A, Figueiredo LT, Lauria FN, Strada G, Brouqui P, Puro V, Krishna S, Kremsner P, Scognamiglio P, Köhler C, Nicastri E, Di Caro A, Cieri RM, Ioannidis JP, Kobinger G, Burattini MN, Ippolito G. Short-term economic impact of the Zika virus outbreak. New Microbiol. 2016 Oct;39(4):287-289.
  102. Magurano F, Baggieri M, Bordi L, Lalle E, Chironna M, Lazzarotto T, Amendola A, Baldanti F, Ansaldi F, Filia A, Declich S, Iannazzo S, Pompa MG, Bucci P, Marchi A, Nicoletti L. Measles in Italy: Co-circulation of B3 variants during 2014. J Med Virol. 2016 Jun;88(6):1081-5. Epub 2015 Nov 6. doi: 10.1002/jmv.24416
  103. Mammone A, Pezzotti P, Regine V, Camoni L, Puro V, Ippolito G, Suligoi B, Girardi E. How many people are living with undiagnosed HIV infection? An estimate for Italy, based on surveillance data. AIDS. 2016 Apr 24;30(7):1131-6. doi: 10.1097/QAD.0000000000001034
  104. Mannocci A, De Carli G, Di Bari V, Saulle R, Unim B, Nicolotti N, Carbonari L, Puro V, La Torre G. How Much do Needlestick Injuries Cost? A Systematic Review of the Economic Evaluations of Needlestick and Sharps Injuries Among Healthcare Personnel. Infect Control Hosp Epidemiol. 2016 Jun;37(6):635-46. doi: 10.1017/ice.2016.48
  105. Marcellusi A, Viti R, Russo S, Andreoni M, Antinori A, Mennini FS. Early Treatment in HIV Patients: A Cost-Utility Analysis from the Italian Perspective. Clin Drug Investig. 2016 May;36(5):377-87. doi: 10.1007/s40261-016-0382-2
  106. Mboera LE, Mweya CN, Rumisha SF, Tungu PK, Stanley G, Makange MR, Misinzo G, De Nardo P, Vairo F, Oriyo NM. The Risk of Dengue Virus Transmission in Dar es Salaam, Tanzania during an Epidemic Period of 2014. PLoS Negl Trop Dis. 2016 Jan 26;10(1):e0004313. eCollection 2016 Jan. doi: 10.1371/journal.pntd.0004313
  107. Meini G, Russo CD, Allice T, Barresi R, D’Arrigo R, Falasca F, Lipsi MR, Paolucci S, Zanussi S, Antonetti R, Baldanti F, Basaglia G, Bruzzone B, Polilli E, Ghisetti V, Pucillo LP, Turriziani O, Pirazzoli A, Navarra P, Zazzi M. First external quality assurance program of the Italian HLA-B*57:01 Network assessing the performance of clinical virology laboratories in HLA-B*57:01 testing. J Clin Virol. 2016 Feb 23;78:1-3. [Epub ahead of print] doi: 10.1016/j.jcv.2016.02.020
  108. Minosse C, Coen S, Visco Comandini U, Lionetti R, Montalbano M, Cerilli S, Vincenti D, Baiocchini A, Capobianchi MR, Menzo S. Simple and Reliable Method to Quantify the Hepatitis B Viral Load and Replicative Capacity in Liver Tissue and Blood Leukocytes. Hepat Mon. 2016 Feb 29;16(10):e28751. doi: 10.5812/hepatmon.28751
  109. Minosse C, Giombini E, Bartolini B, Capobianchi MR, Garbuglia AR. Ultra-Deep Sequencing Characterization of HCV Samples with Equivocal Typing Results Determined with a Commercial Assay. Int J Mol Sci. 2016 Oct 7;17(10). pii: E1679. doi: 10.3390/ijms17101679
  110. Minozzi S, Bonovas S, Lytras T, Pecoraro V, González-Lorenzo M, Bastiampillai AJ, Gabrielli EM, Lonati AC, Moja L, Cinquini M, Marino V, Matucci A, Milano GM, Tocci G, Scarpa R, Goletti D, Cantini F. Risk of infections using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysis. Expert Opin Drug Saf. 2016 Dec;15(sup1):11-34. doi: 10.1080/14740338.2016.1240783
  111. Mocroft A, Lundgren JD, Ross M, Fux CA, Reiss P, Moranne O, Morlat P, Monforte Ad, Kirk O, Ryom L; Data Collection on Adverse events of Anti-HIV Drugs (D:A:D) Study (… Zaccarelli M, Antinori A, Acinapura R, D’Offizi G …). Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with anormal baseline estimated glomerular filtration rate: a prospective international cohort study. Lancet HIV. 2016 Jan;3(1):e23-32. Epub 2015 Nov 17 doi: 10.1016/S2352-3018(15)00211-8.
  112. Mugosa B, Vujosevic D, Ciccozzi M, Valli MB, Capobianchi MR, Lo Presti A, Cella E, Giovanetti M, Lai A, Angeletti S, Scarpa F, Terzić D, Vratnica Z. Genetic diversity of the haemagglutinin (HA) of human influenza a (H1N1) virus in montenegro: Focus on its origin and evolution. J Med Virol. 2016 Nov;88(11):1905-13. doi: 10.1002/jmv.24552
  113. Mulligan N, Schalkwijk S, Best BM, Colbers A, Wang J, Capparelli EV, Moltó J, Stek AM, Taylor G, Smith E, Hidalgo Tenorio C, Chakhtoura N, van Kasteren M, Fletcher CV, Mirochnick M, Burger D and on behalf of the PANNA Network and the IMPAACT 1026s Study Teams (… Nicastri E …). Etravirine Pharmacokinetics in HIV-Infected Pregnant Women. Front Pharmacol. 2016 Aug 4;7:239. eCollection 2016. doi: 10.3389/fphar.2016.00239
  114. Murphy G, Pilcher CD, Keating SM, Kassanjee R, Facente SN, Welte A, Grebe E, Marson K, Busch MP, Dailey P, Parkin N, Osborn J, Ongarello S, Marsh K, Garcia-Calleja JM; Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA) (… Capobianchi MR …).. Moving towards a reliable HIV incidence test – current status, resources available, future directions and challenges ahead. Epidemiol Infect. 2016 Dec 22:1-17. [Epub ahead of print] doi: 10.1017/S0950268816002910
  115. Nazio F, Carinci M, Valacca C, Bielli P, Strappazzon F, Antonioli M, Ciccosanti F, Rodolfo C, Campello S, Fimia GM, Sette C, Bonaldo P, Cecconi F. Fine-tuning of ULK1 mRNA and protein levels is required for autophagy oscillation. J Cell Biol. 2016 Dec 19;215(6):841-856. doi: 10.1083/jcb.201605089
  116. Nicastri E, Balestra P, Ricottini M, Petrosillo N, Di Caro A, Capobianchi MR, Giancola ML, Ippolito G; INMI’s Ebola Team.. Temporary neurocognitive impairment with Ebola virus. J Neurol Neurosurg Psychiatry. 2016 Dec;87(12):1386-1387. doi: 10.1136/jnnp-2016-313695
  117. Nicastri E, Castilletti C, Balestra P, Galgani S, Ippolito G. Zika Virus Infection in the Central Nervous System and Female Genital Tract. Emerg Infect Dis. 2016 Dec 15;22(12). [Epub ahead of print] doi: 10.3201/eid2212.161280
  118. Nicastri E, Castilletti C, Biava M, Fusco FM, Petrosillo N, Puro V, Lauria FN, Capobianchi MR, Di Caro A, Ippolito G. Enabling Rapid Response to the 2014-2016 Ebola Epidemic: The Experience and the Results of the National Institute for Infectious Diseases Lazzaro Spallanzani. Adv Exp Med Biol. 2016 Nov 19. [Epub ahead of print] doi: 10.1007/5584_2016_134
  119. Nicastri E, Castilletti C, Di Caro A, Capobianchi MR, Ippolito G. Diagnosis of Zika virus infection in pregnant women travelling to or residing in endemic areas. Lancet Infect Dis. 2016 Jul;16(7):771-2. doi: 10.1016/S1473-3099(16)30074-3
  120. Nicastri E, Castilletti C, Liuzzi G, Iannetta M, Capobianchi MR, Ippolito G. Persistent detection of Zika virus RNA in semen for six months after symptom onset in a traveller returning from Haiti to Italy, February 2016. Euro Surveill. 2016 Aug 11;21(32). doi: 10.2807/1560-7917.ES.2016.21.32.30314
  121. Nicastri E, Petrosillo N, Vairo F, Di Caro A, Ippolito G. Steroid use and clinical sequelae in two survivors of EVD. Lancet Infect Dis. 2016 Jun;16(6):638. doi: 10.1016/S1473-3099(16)30058-5
  122. Nicastri E, Pisapia R, Corpolongo A, Fusco FM, Cicalini S, Scognamiglio P, Castilletti C, Bordi L, Di Caro A, Capobianchi MR, Puro V, Ippolito G. Three cases of Zika virus imported in Italy: need for a clinical awareness and evidence-based knowledge. BMC Infect Dis. 2016 Nov 11;16(1):669. doi: 10.1186/s12879-016-1973-5
  123. Nisii C, Grunow R, Brave A, Ippolito G, Jacob D, Jureen P, Bartolini B, Di Caro A; EMERGE Viral Pathogens Working Group.. Prioritization of High Consequence Viruses to Improve European Laboratory Preparedness for Cross-Border Health Threats. Adv Exp Med Biol. 2016 Dec 29. [Epub ahead of print] doi: 10.1007/5584_2016_152
  124. Nisii C, Vincenti D, Fusco FM, Schmidt-Chanasit J, Carbonnelle C, Raoul H, Eickmann M, Hewson R, Brave A, Nuncio S, Sanchez-Seco MP, Palyi B, Kis Z, Zange S, Nitsche A, Kurth A, Strasser M, Capobianchi MR, Ozin A, Guglielmetti P, Menel-Lemos C, Jacob D, Grunow R, Ippolito G, Di Caro A. The contribution of the European high containment laboratories during the 2014-2015 Ebola Virus Disease (EVD) emergency. Clin Microbiol Infect. 2016 Jul 9. pii: S1198-743X(16)30227-0. [Epub ahead of print] doi: 10.1016/j.cmi.2016.07.003
  125. Orecchini E, Doria M, Antonioni A, Galardi S, Ciafrè SA, Frassinelli L, Mancone C, Montaldo C, Tripodi M, Michienzi A. ADAR1 restricts LINE-1 retrotransposition. Nucleic Acids Res. 2016 Sep 21. pii: gkw834. [Epub ahead of print] doi: 10.1093/nar/gkw834
  126. Palma P, Zangari P, Alteri C, Tchidjou HK, Manno EC, Liuzzi G, Perno CF, Rossi P, Bertoli A, Bernardi S. Early antiretroviral treatment (eART) limits viral diversity over time in a long-term HIV viral suppressed perinatally infected child. BMC Infect Dis. 2016 Dec 9;16(1):742. doi: 10.1186/s12879-016-2092-z
  127. Pascucci B, D’Errico M, Romagnoli A, De Nuccio C, Savino M, Pietraforte D, Lanzafame M, Calcagnile AS, Fortini P, Baccarini S, Orioli D, Degan P, Visentin S, Stefanini M, Isidoro C, Fimia GM, Dogliotti E. Overexpression of parkin rescues the defective mitochondrial phenotype and the increased apoptosis of Cockayne Syndrome A cells. Oncotarget. 2016 Jun 9. [Epub ahead of print] doi: 10.18632/oncotarget.9913
  128. Pediatric AIDS-Defining Cancer Project Working Group for IeDEA Southern Africa, TApHOD, and COHERE in EuroCoord (… Antinori A …). Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia. Clin Infect Dis. 2016 Nov 1;63(9):1245-1253. doi: 10.1093/cid/ciw519
  129. Pereira GJ, Antonioli M, Hirata H, Ureshino RP, Nascimento AR, Bincoletto C, Vescovo T, Piacentini M, Fimia GM, Smaili SS. Glutamate induces autophagy via the two-pore channels in neural cells. Oncotarget. 2016 Dec 31. [Epub ahead of print] doi: 10.18632/oncotarget.14404
  130. Petersen E, Wilson ME, Touch S, McCloskey B, Mwaba P, Bates M, Dar O, Mattes F, Kidd M, Ippolito G, Azhar EI, Zumla A. Rapid Spread of Zika Virus in The Americas – Implications for Public Health Preparedness for Mass Gatherings at the 2016 Brazil Olympic Games. Int J Infect Dis. 2016 Mar;44:11-5. Epub 2016 Feb 4. doi: 10.1016/j.ijid.2016.02.001
  131. Petrone L, Cannas A, Vanini V, Cuzzi G, Aloi F, Nsubuga M, Sserunkuma J, Nazziwa RA, Jugheli L, Lukindo T, Girardi E, Antinori A, Pucci L, Reither K, Goletti D. Blood and urine inducible protein 10 as potential markers of disease activity. Int J Tuberc Lung Dis. 2016 Nov;20(11):1554-1561. doi: 10.5588/ijtld.16.0342
  132. Petrosillo N, Vranić-Ladavac M, Feudi C, Villa L, Fortini D, Barišić N, Bedenić B, Ladavac R, D’Arezzo S, Andrašević AT, Capone A. Spread of Enterobacter cloacae carrying blaNDM-1, blaCTX-M-15, blaSHV-12 and plasmid-mediated quinolone resistance genes in a surgical intensive care unit in Croatia. J Glob Antimicrob Resist. 2016 Mar;4:44-8. Epub 2015 Nov 14. doi: 10.1016/j.jgar.2015.09.008
  133. Petruccioli E, Chiacchio T, Pepponi I, Vanini V, Urso R, Cuzzi G, Barcellini L, Cirillo DM, Palmieri F, Ippolito G, Goletti D. First characterization of the CD4 and CD8 T-cell responses to QuantiFERON-TB Plus. J Infect. 2016 Dec;73(6):588-597. doi: 10.1016/j.jinf.2016.09.008
  134. Petruccioli E, Navarra A, Petrone L, Vanini V, Cuzzi G, Gualano G, Palmieri F, Girardi E, Goletti D. Use of several immunological markers to model the probability of active tuberculosis. Diagn Microbiol Infect Dis. 2016 Oct;86(2):169-71. doi: 10.1016/j.diagmicrobio.2016.06.007
  135. Petruccioli E, Scriba TJ, Petrone L, Hatherill M, Cirillo DM, Joosten SA, Ottenhoff TH, Denkinger CM, Goletti D. Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis. Eur Respir J. 2016 Dec;48(6):1751-1763. doi: 10.1183/13993003.01012-2016
  136. Pittiruti M, Bertoglio S, Scoppettuolo G, Biffi R, Lamperti M, Dal Molin A, Panocchia N, Petrosillo N, Venditti M, Rigo C, DeLutio E. Evidence-based criteria for the choice and the clinical use of the most appropriate lock solutions for central venous catheters (excluding dialysis catheters): a GAVeCeLT consensus. J Vasc Access. 2016 Nov 2;17(6):453-464. doi: 10.5301/jva.5000576
  137. Podlekareva DN, Efsen AM, Schultze A, Post FA, Skrahina AM, Panteleev A, Furrer H, Miller RF, Losso MH, Toibaro J, Miro JM, Vassilenko A, Girardi E, Bruyand M, Obel N, Lundgren JD, Mocroft A, Kirk O; TB:HIV study group in EuroCoord. Tuberculosis-related mortality in people living with HIV in Europe and Latin America: an international cohort study. Lancet HIV. 2016 Mar;3(3):e120-31. Epub 2016 Feb 2. doi: 10.1016/S2352-3018(15)00252-0
  138. Polilli E, Sozio F, Di Stefano P, Sciacca A, Ursini T, Paoloni M, Vecchiet J, Di Giammartino D, Sciotti MP, Grimaldi A, Cortesi V, Fazii P, Ricci E, D’Amario C, Ippolito G, Pippa L, Parruti G. Web-Based HIV Testing in Abruzzo, Italy: Analysis of 15-Month Activity Results. AIDS Patient Care STDS. 2016 Oct;30(10):471-475. doi: 10.1089/apc.2016.0082
  139. Privitera GP, Costa AL, Brusaferro S, Chirletti P, Crosasso P, Massimetti G, Nespoli A, Petrosillo N, Pittiruti M, Scoppettuolo G, Tumietto F, Viale P. Skin antisepsis with chlorhexidine versus iodine for the prevention of surgical site infection: A systematic review and meta-analysis. Am J Infect Control. 2016 Nov 9. pii: S0196-6553(16)30909-9. [Epub ahead of print] doi: 10.1016/j.ajic.2016.09.017
  140. Puoti M, Lorenzini P, Cozzi-Lepri A, Gori A, Mastroianni C, Rizzardini G, Mazzarello G, Antinori A, Monforte AD, Girardi E; Icona Foundation Study Group.. Incidence and Progression to Cirrhosis of New HCV infections in Persons Living with HIV. Clin Microbiol Infect. 2016 Dec 9. pii: S1198-743X(16)30608-5. [Epub ahead of print] doi: 10.1016/j.cmi.2016.12.003
  141. Puro V, Fusco FM, Petrecchia A, Pittalis S, Antonini M, Bordi L, Lalle E, Castilletti C, Di Caro A, Capobianchi MR, Ippolito G. Sampling Surfaces for Ebola Virus Persistence After Cleaning Procedures in High-Level Isolation Settings: The Experience With 2 Patients at the Lazzaro Spallanzani National Institute for Infectious Diseases. Infect Control Hosp Epidemiol. 2016 Jun;37(6):723-5. doi: 10.1017/ice.2016.46
  142. Qiu X, Audet J, Lv M, He S, Wong G, Wei H, Luo L, Fernando L, Kroeker A, Bovendo HF, Bello A, Li F, Ye P, Jacobs M, Ippolito G, Saphire EO, Bi S, Shen B, Gao GF, Zeitlin L, Feng J, Zhang B, Kobinger GP. Two-mAb cocktail protects macaques against the Makona variant of Ebola virus. Sci Transl Med. 2016 Mar 9;8(329):329ra33. doi: 10.1126/scitranslmed.aad9875
  143. Quick J, Loman NJ, Duraffour S, Simpson JT, Severi E, Cowley L, Bore JA, Koundouno R, Dudas G, Mikhail A, Ouédraogo N, Afrough B, Bah A, Baum JH, Becker-Ziaja B, Boettcher JP, Cabeza-Cabrerizo M, Camino-Sánchez Á, Carter LL, Doerrbecker J, Enkirch T, García-Dorival I, Hetzelt N, Hinzmann J, Holm T, Kafetzopoulou LE, Koropogui M, Kosgey A, Kuisma E, Logue CH, Mazzarelli A, Meisel S, Mertens M, Michel J, Ngabo D, Nitzsche K, Pallasch E, Patrono LV, Portmann J, Repits JG, Rickett NY, Sachse A, Singethan K, Vitoriano I, Yemanaberhan RL, Zekeng EG, Racine T, Bello A, Sall AA, Faye O, Faye O, Magassouba N, Williams CV, Amburgey V, Winona L, Davis E, Gerlach J, Washington F, Monteil V, Jourdain M, Bererd M, Camara A, Somlare H, Camara A, Gerard M, Bado G, Baillet B, Delaune D, Nebie KY, Diarra A, Savane Y, Pallawo RB, Gutierrez GJ, Milhano N, Roger I, Williams CJ, Yattara F, Lewandowski K, Taylor J, Rachwal P, Turner DJ, Pollakis G, Hiscox JA, Matthews DA, O’Shea MK, Johnston AM, Wilson D, Hutley E, Smit E, Di Caro A, Wölfel R, Stoecker K, Fleischmann E, Gabriel M, Weller SA, Koivogui L, Diallo B, Keïta S, Rambaut A, Formenty P, Günther S, Carroll MW. Real-time, portable genome sequencing for Ebola surveillance. Nature. 2016 Feb 11;530(7589):228-32. doi: 10.1038/nature16996
  144. Ricchi M, Mazzarelli A, Piscini A, Di Caro A, Cannas A, Leo S, Russo S, Arrigoni N. Exploring MALDI-TOF MS approach for a rapid identification of Mycobacterium avium ssp. paratuberculosis field isolates. J Appl Microbiol. 2016 Nov 21. [Epub ahead of print] doi: 10.1111/jam.13357
  145. Riccomi A, Gesa V, Sacchi A, De Magistris MT, Vendetti S. Modulation of Phenotype and Function of Human CD4(+)CD25(+) T Regulatory Lymphocytes Mediated by cAMP-Elevating Agents. Front Immunol. 2016 Sep 20;7:358. doi: 10.3389/fimmu.2016.00358
  146. Rodger AJ, Cambiano V, Bruun T, Vernazza P, Collins S, van Lunzen J, Corbelli GM, Estrada V, Geretti AM, Beloukas A, Asboe D, Viciana P, Gutiérrez F, Clotet B, Pradier C, Gerstoft J, Weber R, Westling K, Wandeler G, Prins JM, Rieger A, Stoeckle M, Kümmerle T, Bini T, Ammassari A, Gilson R, Krznaric I, Ristola M, Zangerle R, Handberg P, Antela A, Allan S, Phillips AN, Lundgren J; PARTNER Study Group. Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy. JAMA. 2016 Jul 12;316(2):171-81. doi: 10.1001/jama.2016.5148
  147. Rossi P, Tamarozzi F, Galati F, Pozio E, Akhan O, Cretu CM, Vutova K, Siles-Lucas M, Brunetti E, Casulli A; HERACLES extended network (… Goletti D …). The first meeting of the European Register of Cystic Echinococcosis (ERCE). Parasit Vectors. 2016 Apr 28;9:243. doi: 10.1186/s13071-016-1532-3
  148. Ruibal P, Oestereich L, Lüdtke A, Becker-Ziaja B, Wozniak DM, Kerber R, Korva M, Cabeza-Cabrerizo M, Bore JA, Koundouno FR, Duraffour S, Weller R, Thorenz A, Cimini E, Viola D, Agrati C, Repits J, Afrough B, Cowley LA, Ngabo D, Hinzmann J, Mertens M, Vitoriano I, Logue CH, Boettcher JP, Pallasch E, Sachse A, Bah A, Nitzsche K, Kuisma E, Michel J, Holm T, Zekeng EG, García-Dorival I, Wölfel R, Stoecker K, Fleischmann E, Strecker T, Di Caro A, Avšič-Županc T, Kurth A, Meschi S, Mély S, Newman E, Bocquin A, Kis Z, Kelterbaum A, Molkenthin P, Carletti F, Portmann J, Wolff S, Castilletti C, Schudt G, Fizet A, Ottowell LJ, Herker E, Jacobs T, Kretschmer B, Severi E, Ouedraogo N, Lago M, Negredo A, Franco L, Anda P, Schmiedel S, Kreuels B, Wichmann D, Addo MM, Lohse AW, De Clerck H, Nanclares C, Jonckheere S, Van Herp M, Sprecher A, Xiaojiang G, Carrington M, Miranda O, Castro CM, Gabriel M, Drury P, Formenty P, Diallo B, Koivogui L, Magassouba N, Carroll MW, Günther S, Muñoz-Fontela C. Unique human immune signature of Ebola virus disease in Guinea. Nature. 2016 May 5;533(7601):100-4. doi: 10.1038/nature17949
  149. Russo A, Concia E, Cristini F, De Rosa FG, Esposito S, Menichetti F, Petrosillo N, Tumbarello M, Venditti M, Viale P, Viscoli C, Bassetti M. Current and future trends in antibiotic therapy of acute bacterial skin and skin-structure infections. Clin Microbiol Infect. 2016 Apr;22 Suppl 2:S27-36. doi: 10.1016/S1198-743X(16)30095-7
  150. Ryom L, Lundgren JD, De Wit S, Kovari H, Reiss P, Law M, El-Sadr W, Monforte AD, Mocroft A, Smith C, Fontas E, Dabis F, Phillips A, Sabin C; D:A:D Study Group. (… Antonucci G, Testa A, Narciso P, Vlassi M, Zaccarelli M, Antinori A, Ammassari A, Gallo L, Nicastri E, Acinapura R, Libertone R …). Use of antiretroviral therapy and risk of end-stage liver disease and hepatocellular carcinoma in HIV-positive persons. AIDS. 2016 Jul 17;30(11):1731-43. doi: 10.1097/QAD.0000000000001018
  151. Ryom L, Lundgren JD, Ross M, Kirk O, Law M, Morlat P, Fontas E, Smit C, Fux CA, Hatleberg CI, de Wit S, Sabin CA, Mocroft A; D:A:D Study Group.. (… Zaccarelli M, Antinori A, Acinapura R, Plazzi M …). Renal Impairment and Cardiovascular Disease in HIV-Positive Individuals: The D:A:D Study J Infect Dis. 2016 Oct 15;214(8):1212-20. doi: 10.1093/infdis/jiw342
  152. Sabin CA, Reiss P, Ryom L, Phillips AN, Weber R, Law M, Fontas E, Mocroft A, de Wit S, Smith C, Dabis F, d’Arminio Monforte A, El-Sadr W, Lundgren JD; D:A:D Study Group (… Antonucci G, Testa A, Narciso P, Vlassi C, Zaccarelli M …). Is there continued evidence for an association between abacavir usage and myocardial infarction risk in individuals with HIV? A cohort collaboration. BMC Med. 2016 Mar 31;14:61. doi: 10.1186/s12916-016-0588-4
  153. Santangelo L, Giurato G, Cicchini C, Montaldo C, Mancone C, Tarallo R, Battistelli C, Alonzi T, Weisz A, Tripodi M. The RNA-Binding Protein SYNCRIP Is a Component of the Hepatocyte Exosomal Machinery Controlling MicroRNA Sorting. Cell Rep. 2016 Oct 11;17(3):799-808. doi: 10.1016/j.celrep.2016.09.031
  154. Saracino A, Lorenzini P, Lo Caputo S, Girardi E, Castelli F, Bonfanti P, Rusconi S, Caramello P, Abrescia N, Mussini C, Monno L, d’Arminio Monforte A; ICONA Foundation Study Group. Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: data from the ICONA cohort. Clin Microbiol Infect. 2016 Mar;22(3):288.e1-8. Epub 2015 Nov 10. doi: 10.1016/j.cmi.2015.10.026
  155. Schilling S, Maltezou HC, Fusco FM, De Iaco G, Brodt HR, Bannister B, Brouqui P, Carson G, Puro V, Gottschalk R, Ippolito G; EuroNHID Study-group.. Transportation capacity for patients with highly infectious diseases in Europe: a survey in 16 nations. Clin Microbiol Infect. 2015 Jun 22. pii: S1198-743X(15)00535-2. [Epub ahead of print] doi: 10.1111/1469-0691.12290
  156. Shepherd L, Borges Á, Ledergerber B, Domingo P, Castagna A, Rockstroh J, Knysz B, Tomazic J, Karpov I, Kirk O, Lundgren J, Mocroft A; EuroSIDA in EuroCOORD (… D’Offizi G, Taibi C, Antinori A …). Infection-related and -unrelated malignancies, HIV and the aging population. HIV Med. 2016 Feb 18. [Epub ahead of print] doi: 10.1111/hiv.12359
  157. Simulundu E, Mweene AS, Changula K, Monze M, Chizema E, Mwaba P, Takada A, Ippolito G, Kasolo F, Zumla A, Bates M. Lujo viral hemorrhagic fever: considering diagnostic capacity and preparedness in the wake of recent Ebola and Zika virus outbreaks. Rev Med Virol. 2016 Nov;26(6):446-454. doi: 10.1002/rmv.1903
  158. Sissoko D, Laouenan C, Folkesson E, M’Lebing AB, Beavogui AH, Baize S, Camara AM, Maes P, Shepherd S, Danel C, Carazo S, Conde MN, Gala JL, Colin G, Savini H, Bore JA, Le Marcis F, Koundouno FR, Petitjean F, Lamah MC, Diederich S, Tounkara A, Poelart G, Berbain E, Dindart JM, Duraffour S, Lefevre A, Leno T, Peyrouset O, Irenge L, Bangoura N, Palich R, Hinzmann J, Kraus A, Barry TS, Berette S, Bongono A, Camara MS, Chanfreau Munoz V, Doumbouya L, Souley Harouna, Kighoma PM, Koundouno FR, Réné Lolamou, Loua CM, Massala V, Moumouni K, Provost C, Samake N, Sekou C, Soumah A, Arnould I, Komano MS, Gustin L, Berutto C, Camara D, Camara FS, Colpaert J, Delamou L, Jansson L, Kourouma E, Loua M, Malme K, Manfrin E, Maomou A, Milinouno A, Ombelet S, Sidiboun AY, Verreckt I, Yombouno P, Bocquin A, Carbonnelle C, Carmoi T, Frange P, Mely S, Nguyen VK, Pannetier D, Taburet AM, Treluyer JM, Kolie J, Moh R, Gonzalez MC, Kuisma E, Liedigk B, Ngabo D, Rudolf M, Thom R, Kerber R, Gabriel M, Di Caro A, Wölfel R, Badir J, Bentahir M, Deccache Y, Dumont C, Durant JF, El Bakkouri K, Gasasira Uwamahoro M, Smits B, Toufik N, Van Cauwenberghe S, Ezzedine K, Dortenzio E, Pizarro L, Etienne A, Guedj J, Fizet A, Barte de Sainte Fare E, Murgue B, Tran-Minh T, Rapp C, Piguet P, Poncin M, Draguez B, Allaford Duverger T, Barbe S, Baret G, Defourny I, Carroll M, Raoul H, Augier A, Eholie SP, Yazdanpanah Y, Levy-Marchal C, Antierrens A, Van Herp M, Günther S, de Lamballerie X, Keïta S, Mentre F, Anglaret X, Malvy D; JIKI Study Group. Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea. PLoS Med. 2016 Mar 1;13(3):e1001967. eCollection 2016 Mar. doi: 10.1371/journal.pmed.1001967
  159. Soria A, Alteri C, Scarlatti G, Bertoli A, Tolazzi M, Balestra E, Bellocchi MC, Continenza F, Carioti L, Biasin M, Trabattoni D, Bandera A, Ceccherini-Silberstein F, Perno CF, Gori A. Occupational HIV infection in a research laboratory with unknown mode of transmission: a case report. Clin Infect Dis. 2016 Dec 28. pii: ciw851. [Epub ahead of print] doi: 10.1093/cid/ciw851
  160. Sotgiu G, Tiberi S, D’Ambrosio L, Centis R, Alffenaar JW, Caminero JA, Abdo Arbex M, Alarcon Guizado V, Aleksa A, Dore S, Gaga M, Gualano G, Kunst H, Payen MC, Roby Arias AJ, Skrahina A, Solovic I, Sulis G, Tadolini M, Zumla A, Migliori GB; International Carbapenem Study Group. Faster for less: the new “shorter” regimen for multidrug-resistant tuberculosis. Eur Respir J. 2016 Sep 1. pii: ERJ-01249-2016. [Epub ahead of print] doi: 10.1183/13993003.01249-2016
  161. Squillace N, Galli L, Bandera A, Castagna A, Madeddu G, Caramello P, Antinori A, Cattelan A, Maggiolo F, Cingolani A, Gori A, Monforte Ad; ICONA Foundation Study Group. High-density lipoprotein-cholesterol levels and risk of cancer in HIV-infected subjects: Data from the ICONA Foundation Cohort. Medicine (Baltimore). 2016 Sep;95(36):e4434. doi: 10.1097/MD.0000000000004434
  162. Squillace N, Lorenzini P, Lapadula G, Bandera A, Cozzi-Lepri A, Rusconi S, Puoti M, Castagna A, Antinori A, Gori A, d’Arminio Monforte A; Icona Foundation Study Group.. Triglyceride/HDL ratio and its impact on the risk of diabetes mellitus development during ART. J Antimicrob Chemother. 2016 Sep;71(9):2663-9. doi: 10.1093/jac/dkw185
  163. St John EP, Simen BB, Turenchalk GS, Braverman MS, Abbate I, Aerssens J, Bouchez O, Gabriel C, Izopet J, Meixenberger K, Di Giallonardo F, Schlapbach R, Paredes R, Sakwa J, Schmitz-Agheguian GG, Thielen A, Victor M, Metzner KJ, Däumer MP; 454 HIV-1 Alpha Study Group. A Follow-Up of the Multicenter Collaborative Study on HIV-1 Drug Resistance and Tropism Testing Using 454 Ultra Deep Pyrosequencing. PLoS One. 2016 Jan 12;11(1):e0146687. eCollection 2016. doi: 10.1371/journal.pone.0146687
  164. Strappazzon F, Di Rita A, Cianfanelli V, D’Orazio M, Nazio F, Fimia GM, Cecconi F. Prosurvival AMBRA1 turns into a proapoptotic BH3-like protein during mitochondrial apoptosis. Autophagy. 2016 Jun 2;12(6):963-75. doi: 10.1080/15548627.2016.1164359
  165. Stroffolini T, Chini F, Scognamiglio P, Capobianchi MR, Arcà M, Ippolito G, Girardi E. Temporal trend of hospital discharge for non alcoholic cirrhosis in Lazio Region, Italy 2000-2014. Eur J Intern Med. 2016 May 19. pii: S0953-6205(16)30087-5. [Epub ahead of print] doi: 10.1016/j.ejim.2016.04.018
  166. Tacconelli E, Cataldo MA, Paul M, Leibovici L, Kluytmans J, Schröder W, Foschi F, De Angelis G, De Waure C, Cadeddu C, Mutters NT, Gastmeier P, Cookson B. STROBE-AMS: recommendations to optimise reporting of epidemiological studies on antimicrobial resistance and informing improvement in antimicrobial stewardship. BMJ Open. 2016 Feb 19;6(2):e010134. doi: 10.1136/bmjopen-2015-010134
  167. TenoRes Study Group (… Antinori A, Perno CF …). Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study. Lancet Infect Dis. 2016 May;16(5):565-75 doi: 10.1016/S1473-3099(15)00536-8.
  168. Thiébaut R, Jarne A, Routy JP, Sereti I, Fischl M, Ive P, Speck RF, D’Offizi G, Casari S, Commenges D, Foulkes S, Natarajan V, Croughs T, Delfraissy JF, Tambussi G, Levy Y, Lederman MM. Repeated Cycles of Recombinant Human Interleukin 7 in HIV-Infected Patients With Low CD4 T-Cell Reconstitution on Antiretroviral Therapy: Results of 2 Phase II Multicenter Studies. Clin Infect Dis. 2016 May 1;62(9):1178-85. doi: 10.1093/cid/ciw065
  169. Tiberi S, Payen MC, Sotgiu G, D’Ambrosio L, Alarcon Guizado V, Alffenaar JW, Abdo Arbex M, Caminero JA, Centis R, De Lorenzo S, Gaga M, Gualano G, Roby Arias AJ, Scardigli A, Skrahina A, Solovic I, Sulis G, Tadolini M, Akkerman OW, Alarcon Arrascue E, Aleska A, Avchinko V, Bonini EH, Chong Marín FA, Collahuazo López L, de Vries G, Dore S, Kunst H, Matteelli A, Moschos C, Palmieri F, Papavasileiou A, Spanevello A, Vargas Vasquez D, Viggiani P, White V, Zumla A, Migliori GB. Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB. Eur Respir J. 2016 Apr;47(4):1235-43. Epub 2016 Mar 10. doi: 10.1183/13993003.02146-2015
  170. Tiberi S, Sotgiu G, D’Ambrosio L, Centis R, Abdo Arbex M, Alarcon Arrascue E, Alffenaar JW, Caminero JA, Gaga M, Gualano G, Skrahina A, Solovic I, Sulis G, Tadolini M, Alarcon Guizado V, De Lorenzo S, Roby Arias AJ, Scardigli A, Akkerman OW, Aleksa A, Artsukevich J, Auchynka V, Bonini EH, Chong Marín FA, Collahuazo López L, de Vries G, Dore S, Kunst H, Matteelli A, Moschos C, Palmieri F, Papavasileiou A, Payen MC, Piana A, Spanevello A, Vargas Vasquez D, Viggiani P, White V, Zumla A, Migliori GB. Comparison of effectiveness and safety of imipenem/clavulanate- versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB. Eur Respir J. 2016 Jun;47(6):1758-66. Epub 2016 Apr 13 doi: 10.1183/13993003.00214-2016
  171. Tiberi S, Sotgiu G, D’Ambrosio L, Centis R, Arbex MA, Alarcon Arrascue E, Alffenaar JW, Caminero JA, Gaga M, Gualano G, Skrahina A, Solovic I, Sulis G, Tadolini M, Alarcon Guizado V, De Lorenzo S, Roby Arias AJ, Scardigli A, Akkerman OW, Aleksa A, Artsukevich J, Avchinko V, Bonini EH, Chong Marín FA, Collahuazo López L, de Vries G, Dore S, Kunst H, Matteelli A, Moschos C, Palmieri F, Papavasileiou A, Payen MC, Piana A, Spanevello A, Vargas Vasquez D, Viggiani P, White V, Zumla A, Migliori GB. Effectiveness and Safety of Imipenem-Clavulanate Added to an Optimized Background Regimen (OBR) Versus OBR Control Regimens in the Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis. Clin Infect Dis. 2016 May 1;62(9):1188-90. doi: 10.1093/cid/ciw088
  172. Uyeki TM, Mehta AK, Davey RT Jr, Liddell AM, Wolf T, Vetter P, Schmiedel S, Grünewald T, Jacobs M, Arribas JR, Evans L, Hewlett AL, Brantsaeter AB, Ippolito G, Rapp C, Hoepelman AI, Gutman J; Working Group of the U.S.–European Clinical Network on Clinical Management of Ebola Virus Disease Patients in the U.S. and Europe. Clinical Management of Ebola Virus Disease in the United States and Europe. N Engl J Med. 2016 Feb 18;374(7):636-46. doi: 10.1056/NEJMoa1504874
  173. Vairo F, Mboera LE, De Nardo P, Oriyo NM, Meschi S, Rumisha SF, Colavita F, Mhina A, Carletti F, Mwakapeje E, Capobianchi MR, Castilletti C, Di Caro A, Nicastri E, Malecela MN, Ippolito G. Clinical, Virologic, and Epidemiologic Characteristics of Dengue Outbreak, Dar es Salaam, Tanzania, 2014. Emerg Infect Dis. 2016 May;22(5):895-9. doi: 10.3201/eid2205.151462
  174. Van der Auwera G, Bart A, Chicharro C, Cortes S, Davidsson L, Di Muccio T, Dujardin JC, Felger I, Paglia MG, Grimm F, Harms G, Jaffe CL, Manser M, Ravel C, Robert-Gangneux F, Roelfsema J, Töz S, Verweij JJ, Chiodini PL. Comparison of Leishmania typing results obtained from 16 European clinical laboratories in 2014. Euro Surveill. 2016 Dec 8;21(49). pii: 30418. doi: 10.2807/1560-7917.ES.2016.21.49.30418
  175. . van Lunzen J, Antinori A, Cohen CJ, Arribas JR, Wohl DA, Rieger A, Rachlis A, Bloch M, Segal-Maurer S, Garner W, Porter D, Bosse M, Piontkowsky D, Chuck SK, De-Oertel S. Rilpivirine vs. efavirenz-based single-tablet regimens in treatment-naive adults: week 96 efficacy and safety from a randomized phase 3b study. AIDS. 2016 Jan;30(2):251-9. doi: 10.1097/QAD.0000000000000911
  176. van Lunzen J, Pozniak A, Gatell JM, Antinori A, Klauck I, Serrano O, Baakili A, Osiyemi O, Sevinsky H, Girard PM. Brief Report: Switch to Ritonavir-Boosted Atazanavir Plus Raltegravir in Virologically Suppressed Patients With HIV-1 Infection: A Randomized Pilot Study. J Acquir Immune Defic Syndr. 2016 Apr 15;71(5):538-43. doi: 10.1097/QAI.0000000000000904
  177. Venditti C, Villa L, Capone A, Fortini D, D’Arezzo S, Nisii C, Bordi E, Puro V, Antonini M, Carattoli A, Cataldo MA, Petrosillo N, Di Caro A. Isolation of KPC 3-producing Enterobacter aerogenes in a patient colonized by MDR Klebsiella pneumoniae. New Microbiol. 2016 Oct;39(4):310-313.
  178. Vescovo T, Refolo G, Vitagliano G, Fimia GM, Piacentini M. Molecular mechanisms of hepatitis C virus-induced hepatocellular carcinoma. Clin Microbiol Infect. 2016 Oct;22(10):853-861. doi: 10.1016/j.cmi.2016.07.019
  179. Wang Q, De Luca A, Smith C, Zangerle R, Sambatakou H, Bonnet F, Smit C, Schommers P, Thornton A, Berenguer J, Peters L, Spagnuolo V, Ammassari A, Antinori A, Roldan EQ, Mussini C, Miro JM, Konopnicki D, Fehr J, Campbell MA, Termote M, Bucher HC; Hepatitis Coinfection and Non Hodgkin Lymphoma project team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord.. Chronic Hepatitis B and C Virus Infection and Risk for Non-Hodgkin Lymphoma in HIV-Infected Patients: A Cohort Study. Ann Intern Med. 2016 Oct 18. [Epub ahead of print] doi: 10.7326/M16-0240
  180. Winston A, Stöhr W, Antinori A, Amieva H, Perré P, De Wit S, Reynes J, Gompels M, Monforte AD, Gatell JM, Grarup J, Pozniak A, Babiker A, Raffi F, Richert L; NEAT 001ANRS 143 Study Group.. Changes in Cognitive Function Over 96 weeks in Naïve Patients Randomised to Darunavir-ritonavir plus either Raltegravir or Tenofovir-Emtricitabine: a substudy of the NEAT001/ANRS143 trial. J Acquir Immune Defic Syndr. 2016 Oct 3. [Epub ahead of print] doi: 10.1097/QAI.0000000000001189
  181. Wurtz N, Papa A, Hukic M, Di Caro A, Leparc-Goffart I, Leroy E, Landini MP, Sekeyova Z, Dumler JS, Bădescu D, Busquets N, Calistri A, Parolin C, Palù G, Christova I, Maurin M, La Scola B, Raoult D. Survey of laboratory-acquired infections around the world in biosafety level 3 and 4 laboratories. Eur J Clin Microbiol Infect Dis. 2016 Aug;35(8):1247-58. doi: 10.1007/s10096-016-2657-1
  182. Zaccarelli M, Santoro MM, Armenia D, Borghi V, Gennari W, Gori C, Forbici F, Bertoli A, Fabeni L, Giannetti A, Cicalini S, Bellagamba R, Andreoni M, Mastroianni CM, Mussini C, Ceccherini-Silberstein F, Perno CF, Antinori A. Genotypic resistance test in proviral DNA can identify resistance mutations never detected in historical genotypic test in patients with low level or undetectable HIV-RNA. J Clin Virol. 2016 Jul 18;82:94-100. [Epub ahead of print] doi: 10.1016/j.jcv.2016.07.007
  183. Zumla A, Dar O, Kock R, Muturi M, Ntoumi F, Kaleebu P, Eusebio M, Mfinanga S, Bates M, Mwaba P, Ansumana R, Khan M, Alagaili AN, Cotten M, Azhar EI, Maeurer M, Ippolito G, Petersen E. Taking forward a ‘One Health’ approach for turning the tide against the Middle East respiratory syndrome coronavirus and other zoonotic pathogens with epidemic potential. Int J Infect Dis. 2016 Jun;47:5-9. doi: 10.1016/j.ijid.2016.06.012
  184. Zumla A, Rao M, Wallis RS, Kaufmann SH, Rustomjee R, Mwaba P, Vilaplana C, Yeboah-Manu D, Chakaya J, Ippolito G, Azhar E, Hoelscher M, Maeurer M; Host-Directed Therapies Network consortium. Host-directed therapies for infectious diseases: current status, recent progress, and future prospects. Lancet Infect Dis. 2016 Apr;16(4):e47-63. doi: 10.1016/S1473-3099(16)00078-5
Torna all'inizio dei contenuti